BK1301 DTaP vaccine booster

BK1301 · Tanabe Pharma Corporation

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BK1301 DTaP vaccine booster, covering 2016-11-21 to 2016-11-21. Get the full timeline:

Most recent: Clinical Trial Update: Study of BK1301 (DTaP Vaccine) as a Booster in Adolescents [Phase 3]